Researchers Find New Arrhythmia Drug Provides Only Modest Efficacy And No Clear Safety Benefits

Links shared publicly online about this topic.

  • 1,260
    total visits

Researchers Find New Arrhythmia Drug Provides Only Modest Efficacy And No Clear Safety Benefits

medicalnewstoday.com

In a rigorous new review of the antiarrhythmic drug dronedarone (Multaq), researchers at the Cedars-Sinai Heart Institute conclude that the controversial drug is only modestly effective and has no

View full resource at medicalnewstoday.com

Tags: Heart, Heart Disease, Arrhythmia, Drug, Antiarrhythmic Medication, Multaq

  • Share

Most Recently Shared on April 6, 2010 at 6:09 pm By:

mnt_cardiovasc MNT Cardiovascular

Researchers Find New Arrhythmia Drug Provides Only Modest Efficacy And No Clear Safety Benefits http://mnt.to/3zSc #cardiovascular

2 years ago...

Also Shared By:

Heart Health Heart Health

Mona  Jauhar Mona Jauhar

Controversial Arrhythmia Drug Provides Only Modest Efficacy And No Clear Safety Benefits

medicalnewstoday.com — “In a rigorous new review of the antiarrhythmic drug dronedarone (Multaq), researchers at the Cedars-Sinai Heart Institute conclude that the controversial drug is only modestly effective and has noView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on April 6, 2010 at 1:07 pm By:

medical_tweets medical_tweets Health News

Controversial Arrhythmia Drug Provides Only Modest Efficacy And No Clear Safety Benefits In a rigorous new review of the.. http://dld.bz/dJr

2 years ago...

New arrhythmia drug provides only modest efficacy and no clear safety benefits, say researchers

sciencedaily.com — “In a rigorous new review of the antiarrhythmic drug dronedarone (Multaq), researchers conclude that the controversial drug is only modestly effective and has no clear safety benefits.View full resource at sciencedaily.com

  • View Related
  • Share

Most Recently Shared on April 6, 2010 at 1:08 am By:

sciencedaily sciencedaily Health News

New arrhythmia drug provides only modest efficacy and no clear safety benefits, say researchers: In a rigorous new... http://bit.ly/d923eV

2 years ago...

New arrhythmia drug provides only modest efficacy and no clear safety benefits say researchers

physorg.com — “In a rigorous new review of the antiarrhythmic drug dronedarone (Multaq), researchers at the Cedars-Sinai Heart Institute conclude that the controversial drug is only modestly effective and has no clear safety benefits.View full resource at physorg.com

  • View Related
  • Share

Most Recently Shared on April 5, 2010 at 10:32 pm By:

monajauharRD Mona Jauhar Health Professional

New arrhythmia drug provides only modest efficacy and no clear safety benefits say researchers: In a rigorous new ... http://bit.ly/azm7g2

2 years ago...

Advertisement